Genetic animal models: focus on schizophrenia
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 24 (9) , 527-533
- https://doi.org/10.1016/s0166-2236(00)01886-5
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New EvidenceAnnual Review of Pharmacology and Toxicology, 2001
- Long-trace interval eyeblink conditioning is impaired in mutant mice lacking the NMDA receptor subunit ε1European Journal of Neuroscience, 2001
- The Role of Serotonin in Antipsychotic Drug ActionNeuropsychopharmacology, 1999
- NEW INSIGHTS INTO DOPAMINERGIC RECEPTOR FUNCTION USING ANTISENSE AND GENETICALLY ALTERED ANIMALSAnnual Review of Pharmacology and Toxicology, 1999
- Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic toneJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal deathPublished by Elsevier ,1994
- PCP site 2: A high affinity MK-801-insensitive phencyclidine binding siteNeurotoxicology and Teratology, 1994
- Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout micePublished by Elsevier ,1994
- Animal models of human genetic diseasesTrends in Genetics, 1993
- Dopamine receptors and the dopamine hypothesis of schizophreniaSynapse, 1987